Development of artificial intelligence-assisted deprescribing chatbot for patients with cystic fibrosis discontinuing proton pump inhibitors
Background Supporting deprescribing of proton pump inhibitors (PPIs) is critical for patients with cystic fibrosis (CF), as long-term use may lead to adverse outcomes. Deprescribing barriers include patient access to healthcare providers (HCPs) and health information, as well as HCP time and knowled...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis Group
2025-12-01
|
| Seri Bilgileri: | Health Literacy and Communication Open |
| Konular: | |
| Online Erişim: | https://www.tandfonline.com/doi/10.1080/28355245.2025.2536511 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|